Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

MorphoSys AG. (11/7/14). "Press Release: MorphoSys AG Reports Results for the First Nine Months of 2014. Increased EBIT Guidance Confirmed".

Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group MorphoSys (Group)
  Organisation 2 Lanthio Pharma B.V.
  Group MorphoSys (Group)
Products Product MOR209/ES414 (MorphoSys/Emergent)
  Product 2 LanthioPep technology
  Index term 2 MorphoSys–Emergent BioSolutions: antibody cancer drug, 201408– collab developm + commercialisation rights or ES414 outside North America for MorphoSys
Person Person Gutjahr-Löser, Claudia (MC Services 201710– Managing Director before MorphoSys 2002–2017 + Cassiopeia + Deutsche Bank)
     


   
Record changed: 2017-04-02

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for MorphoSys (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top